Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06931977 · ClinicalTrials.gov registry record · NA
Natural Product System and Lifestyle Modification
A NA study, sponsored by dōTERRA International.
- Completed
- Registry status
- NA
- Development phase
- 97
- Enrollment target
NCT06931977: Completed NA study, sponsored by dōTERRA International.
NCT06931977 is a NA study that has completed, run by dōTERRA International. The registered enrollment target is 97 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06931977, a NA study, has completed, sponsored by dōTERRA International.
- COMPLETED
- Registry status
- NA
- Development phase
- 97 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to learn whether four dietary supplements and lifestyle changes can affect gene expression and blood markers in healthy volunteers. The main questions it aims to answer are: 1. How does daily ingestion of dietary supplements affect gene expression and hsCRP and vitamin D levels measured in blood? 2. How does daily ingestion of dietary supplements affect anthropometric measurements, sleep and physical activity, and gut microbiome composition? 3. How does daily ingestion of dietary supplements affect cognitive and subjective health parameters? 4. Do prescriptive lifestyle modifications affect the supplements' efficacy? 5. Is there a difference in outcomes between participants who take all four study supplements and those who take three study supplements with a placebo? 6. Is ingesting dietary supplements for 12 weeks safe, as measured by laboratory tests and adverse events?
Interventions
- DIETARY_SUPPLEMENT Supplement system + copaiba softgels
- DIETARY_SUPPLEMENT Supplement system + placebo softgels
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 97 participants |
| Start Date | 2025-04-29 |
| Est. Completion | 2025-09-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06931977
The ClinicalTrials.gov registry entry for NCT06931977 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 97 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is dōTERRA International, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Supplement system + copaiba softgels is the first listed.
NCT06931977 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06931977 about?
NCT06931977 is a clinical study titled "Natural Product System and Lifestyle Modification". The goal of this clinical trial is to learn whether four dietary supplements and lifestyle changes can affect gene expression and blood markers in healthy volunteers. The main questions it aims to answer are: 1. How does daily ingestion of dietary supplements affect gene expression and hsCRP and vi...
What is the current status of trial NCT06931977?
This trial is currently completed. It is a NA study. The enrollment target is 97 participants. The study started on 2025-04-29. Estimated completion is 2025-09-03.
What interventions are being tested in trial NCT06931977?
The interventions under investigation include: Supplement system + copaiba softgels (DIETARY_SUPPLEMENT), Supplement system + placebo softgels (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06931977?
This trial is sponsored by dōTERRA International, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.